These findings suggest potential neuroprotective benefits of semaglutide, especially regarding cognitive health, and call for further research to validate its use in treating cognitive deficits and substance misuse in patients with T2DM (87)
Oral Wegovy was FDA approved in late December 2025
Slow Titration: She strictly adheres to a start low, go slow philosophy
En total 9340 individuos fueron incluidos y seguidos desde el 2010 al 2012, evidenciando un menor riesgo de eventos cardiovasculares primarios (mortalidad, infarto e ictus no fatal) en los pacientes tratados con liraglutida (HR=0,87
Weight loss injections, primarily glucagon-like peptide-1 (GLP-1) receptor agonists, work through multiple physiological mechanisms to promote weight reduction
If an unopened pen is left unrefrigerated or exposed to improper temperatures, the medication may lose effectiveness in managing blood sugar levels and should be discarded rather than used